An estimated 32,000 Americans are currently living with ALS, or amyotrophic lateral sclerosis, a progressive neurodegenerative disease that attacks motor neurons in the brain and spinal cord.
Northwestern investigators have uncovered novel cellular mechanisms involved in two types of genetic ALS that might lead to future targeted therapies. Evangelos Kiskinis, PhD, shares insights on these findings recently published in Science Advances and Cell Reports.
The Evolution of Digital Pathology with Lee Cooper, PhD
Driving Innovations in Biostatistics with Denise Scholtens, PhD
Leading Pediatric Obesity Research with Justin Ryder, PhD
Pursuing Deeper Understanding of Inflammation with Murali Prakriya, PhD
Partnering with Libraries to Address Teen Mental Health with Ashley Knapp, PhD, and Robert Simmons, MA
Engineering Bacteria to Monitor and Treat Disease with Arthur Prindle, PhD
Strengthening T-Cell Therapy for Solid Tumor Cancers with Jaehyuk Choi, MD, PhD
New Insights into Dopamine with Raj Awatramani, PhD, and Daniel Dombeck, PhD
The Evolution of the NIH Toolbox with Richard Gershon, PhD
How Mitochondria Inform Disease Discoveries with Navdeep Chandel, PhD
Advancing Transplant Science with Daniela Ladner, MD, MPH
How Drinking Alcohol Impacts Aging with Lifang Hou, MD, PhD
How AI Can Improve Healthcare Delivery with Mozzi Etemadi, MD, PhD
Predicting Which Cancer Cells May Become Drug-Resistant with Yogesh Goyal, PhD
New Institute Advances Lung Disease Research and Clinical Care with Scott Budinger, MD
Understanding Genetic Factors in Parkinson's Disease with Steven Lubbe, PhD
Why Late-Night Eating is Linked to Weight Gain and Diabetes with Joseph Bass, MD, PhD
Rewind: A Promising Obesity Drug with Robert Kushner, MD
Improving Exercise Habits for Breast Cancer Survivors with Siobhan Phillips, PhD, MPH
Create your
podcast in
minutes
It is Free
The Insightful Leader
Northwestern Intersections
One Book, One Northwestern: The Podcast
NorthwesternU